Michigan 2025-2026 Regular Session

Michigan Senate Bill SB0094

Introduced
2/20/25  
Refer
2/20/25  
Report Pass
2/26/25  
Refer
2/26/25  
Report Pass
3/5/25  
Engrossed
3/6/25  

Caption

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25

Impact

The enactment of SB 94 is expected to have a significant impact on state laws regarding drug distribution and pharmaceutical practices. Specifically, it mandates that covered entities involved in the 340B program must submit reports annually to state departments and legislative bodies. This reporting includes various compliance and performance measures, which are intended to ensure adherence to both state and federal regulations, promote transparency, and evaluate the impact of these programs on local communities.

Summary

Senate Bill 94 aims to amend the Public Health Code in Michigan by adding provisions related to the federal 340B drug pricing program. The bill prohibits manufacturers, wholesalers, and wholesale distributor-brokers from denying or limiting the acquisition of 340B drugs by entities that participate in the program or their contracted pharmacies. This legislative effort is designed to enhance accessibility to affordable medication for community health organizations that rely on the 340B program for providing services to underserved populations.

Sentiment

The sentiment surrounding SB 94 is generally supportive among healthcare advocates and community organizations that prioritize equitable access to medications. Proponents view this bill as a crucial step in safeguarding the benefits of the 340B program, which serves essential health services for the low-income and uninsured populations. However, there may also be concerns about the administrative burden placed on 340B entities and whether the increased regulatory oversight could discourage participation in the program.

Contention

Notable points of contention regarding SB 94 may arise from pharmaceutical industry stakeholders who could perceive the reporting requirements as restrictive or cumbersome. As the bill interlinks with other pending legislation, its effectiveness will depend on the successful passage of related bills that could impact the overall framework of healthcare regulations in Michigan. The discussions may highlight the balance between ensuring access to affordable drugs and the viability of pharmaceutical companies operating within the state.

Companion Bills

MI SB0095

Same As Health facilities: hospitals; collection of debts; prohibit if hospital is not in compliance with price transparency laws. Creates new act. TIE BAR WITH: SB 0094'25

Previously Filed As

MI SB1179

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0952'24

MI HB5350

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c.

MI HB5436

Health occupations: pharmacists; pharmacists to prescribe and dispense certain contraceptives; allow. Amends secs. 17703, 17704, 17707, 17708, 17709, 17744, 17751 & 17757 of 1978 PA 368 (MCL 333.17703 et seq.) & adds sec. 17744g.

MI SB0219

Health occupations: pharmacists; pharmacists to order and administer certain vaccines and laboratory tests and dispense drugs under certain circumstances; allow. Amends secs. 9204, 9206, 17703, 17707, 17708, 17713, 17751 & 17757 of 1978 PA 368 (MCL 333.9204 et seq.) & adds secs. 17724 & 17724a.

MI HB4409

Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act.

MI SB0563

Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for. Creates new act.

MI SB0483

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

MI HB4435

Health occupations: pharmacists; pharmacists to order and administer vaccines under certain circumstances; allow. Amends secs. 9204 & 17707 of 1978 PA 368 (MCL 333.9204 & 333.17707) & adds sec. 17724.

MI SB0680

Health: occupations; licensing sanctions for compliance with death with dignity act; prohibit under certain circumstances. Amends secs. 17752 & 20175 of 1978 PA 368 (MCL 333.17752 & 333.20175) & adds sec. 16221c. TIE BAR WITH: SB 0681'23

MI HB6143

Health occupations: pharmacists; availability of prescription readers; require. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17756a.

Similar Bills

MI SB1179

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0952'24

MS SB2715

Pharmaceuticals; authorize the Division of Medicaid to establish a wholesale prescription drug importation program.

MS SB2733

Pharmaceuticals; authorize the Division of Medicaid to establish a wholesale prescription drug importation program.

NJ A3621

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

NJ S1667

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

NJ A2240

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

CA SB17

Health care: prescription drug costs.

MS SB2012

Mississippi Health Care Cost Transparency Act; enact.